Nexalin Technology Correlations
NXLIW Stock | USD 0.20 0.22 52.38% |
The current 90-days correlation between Nexalin Technology and NexGel Warrant is -0.02 (i.e., Good diversification). The correlation of Nexalin Technology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Nexalin Technology Correlation With Market
Average diversification
The correlation between Nexalin Technology and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nexalin Technology and DJI in the same portfolio, assuming nothing else is changed.
Nexalin |
Moving together with Nexalin Stock
0.77 | GH | Guardant Health | PairCorr |
0.79 | LH | Laboratory | PairCorr |
0.64 | MD | Mednax Inc | PairCorr |
0.62 | DOCS | Doximity Sell-off Trend | PairCorr |
0.68 | DXCM | DexCom Inc | PairCorr |
0.84 | VREX | Varex Imaging Corp | PairCorr |
0.71 | XAIR | Beyond Air | PairCorr |
0.78 | CAH | Cardinal Health | PairCorr |
0.71 | LNSR | LENSAR Inc | PairCorr |
Moving against Nexalin Stock
0.82 | VERO | Venus Concept | PairCorr |
0.74 | DRIO | DarioHealth Corp Buyout Trend | PairCorr |
0.82 | GCTK | GlucoTrack | PairCorr |
0.81 | FIGS | Figs Inc | PairCorr |
0.75 | ELAB | Elevai Labs, Common | PairCorr |
0.75 | XTNT | Xtant Medical Holdings | PairCorr |
0.71 | TFX | Teleflex Incorporated | PairCorr |
0.62 | MASS | 908 Devices | PairCorr |
0.47 | MOH | Molina Healthcare | PairCorr |
0.32 | CVS | CVS Health Corp Sell-off Trend | PairCorr |
0.81 | MNDR | Mobile health Network | PairCorr |
0.76 | TNONW | Tenon Medical, Warrant | PairCorr |
0.57 | MHUA | Meihua International | PairCorr |
0.48 | MODD | Modular Medical | PairCorr |
0.44 | MGRX | Mangoceuticals, Common | PairCorr |
0.43 | MGRM | Monogram Orthopaedics | PairCorr |
Related Correlations Analysis
-0.28 | 0.04 | 0.02 | -0.5 | NXGLW | ||
-0.28 | -0.07 | 0.2 | 0.07 | PETVW | ||
0.04 | -0.07 | 0.21 | 0.23 | NLSPW | ||
0.02 | 0.2 | 0.21 | -0.08 | HSCSW | ||
-0.5 | 0.07 | 0.23 | -0.08 | IINNW | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Nexalin Stock performing well and Nexalin Technology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nexalin Technology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NXGLW | 8.40 | 1.32 | 0.12 | (0.56) | 8.29 | 25.00 | 60.67 | |||
PETVW | 10.99 | 1.27 | 0.07 | 0.95 | 12.95 | 32.50 | 83.90 | |||
NLSPW | 25.11 | 5.95 | 0.22 | 0.71 | 20.07 | 81.82 | 190.13 | |||
HSCSW | 19.14 | 4.66 | 0.20 | 6.50 | 14.82 | 69.52 | 150.00 | |||
IINNW | 9.68 | 0.37 | 0.02 | (1.06) | 11.08 | 24.14 | 151.39 |
Nexalin Technology Corporate Management
Marilyn Elson | Chief Officer | Profile | |
Joel Bradus | Director Marketing | Profile | |
Carolyn Shelton | Regulatory Quality | Profile | |
David MD | Chief Director | Profile | |
Michael Nketiah | Regulatory Quality | Profile |